Trial Results

January 26, 2022
Doctor feels patient's throat

Trial Results: Journal of Clinical Oncology Publishes Final Results of E3311 Phase II Trial for Head and Neck Cancer

A new post-surgery approach for treating HPV-related throat cancer uses less radiation safely and spares the majority of patients from chemotherapy
December 22, 2021
Research definition

ECOG-ACRIN Research at ASH 2021

Researchers with the Leukemia, Lymphoma, and Myeloma Committees presented a range of findings pertaining to treatments, patient-reported outcomes, and genomics
November 16, 2021
Doctor patient skin exam

Trial Results: ASCO Highlights Practice-Changing Results in Melanoma

The phase III DREAMseq clinical trial provides strong evidence for starting treatment with combination immunotherapy then giving targeted therapy if the disease progresses in patients with BRAF V600 mutant metastatic melanoma
July 7, 2021
TMIST recruitment graph

Trial Updates: TMIST Enrollment Hits 50,000; NCI-MATCH News; Recent Research Results

Recent ECOG-ACRIN trial updates and results
May 28, 2021
Female doctor on laptop

ECOG-ACRIN and PrECOG Research at ASCO 2021

Researchers with the ECOG-ACRIN Cancer Research Group and PrECOG, LLC will present a wide range of research findings at the 2021 ASCO Annual Meeting
January 25, 2021
Pink Rubik's cube

Joe Sparano: Refining Individual Risk in Breast Cancer

Dr. Sparano discusses the scientific and statistical collaboration behind a new tool, RSClin™, which integrates clinical–pathological and genomic risk information to guide adjuvant chemotherapy in node-negative breast cancer
October 19, 2020

Trial Results: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

The Journal of Clinical Oncology published new data from the NCI-MATCH precision medicine cancer trial that has broad relevance in medicine and provides a roadmap for future precision medicine trials
September 14, 2020
PrECOG logo

Trial Results: PALbociclib CoLlaborative Adjuvant Study (PALLAS)

A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence
July 29, 2020

Trial Results: E3311 Leads to Phase III Trial in Head and Neck Cancer

Learn more about a less intense treatment that preserves throat function and spares unnecessary toxicities
June 10, 2020
E2112 video image

Trial Results: E2112 Finds No Significant Overall Survival Benefit With Entinostat/Exemestane in Advanced Breast Cancer

The study results, as well as correlative analyses, will be reported in an upcoming medical meeting
April 15, 2020
Brain fog image

Trial Results: TAILORx Cognition Data in JCO and EA1141 Brief MRI vs 3-D in JAMA

February 28, 2020
News in Brief

News in Brief, February 2020